Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07925996
NA

Dermal Priming in Enhancing Vaccine Immunogenicity

Sponsor: Cambridge University Hospitals NHS Foundation Trust

View on ClinicalTrials.gov

Summary

Experimental medicine study in patients receiving B cell depletion therapy administering an immune challenge with seasonal influenza vaccination with/without concurrent administration of topical imiquimod (TLR7 agonist) aiming to determine proof of concept that local dermal immune priming alters physiological parameters following immunisation in this context.

Official title: Understanding the Impact of Local Dermal Priming in Enhancing Vaccine Immunogenicity in Patients Receiving B Cell Depleting Immunosuppression

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

28

Start Date

2025-12-15

Completion Date

2027-06-30

Last Updated

2026-11-09

Healthy Volunteers

No

Interventions

DRUG

Imiquimod (topical use)

Topical application at site of influenza vaccine administration

DRUG

Aqueous cream

Topical aqueous cream

Locations (1)

Cambridge University Hospitals NHS Foundation Trust

Cambridge, United Kingdom